# Drug-disease networks and drug repurposing

## TL;DR

This paper introduces a new drug-disease network and uses network-based methods to identify promising drug repurposing candidates with high accuracy.

## Contribution

A novel drug-disease network and improved link prediction methods for drug repurposing with high predictive performance.

## Key findings

- Network-based link prediction methods outperform previous approaches in identifying viable drug-disease combinations.
- Graph embedding and network model fitting methods achieved an area under the ROC curve above 0.95.
- Average precision was nearly a thousand times better than random chance in cross-validation tests.

## Abstract

Repurposing existing drugs to treat new diseases is a cost-effective alternative to de novo drug development, but there are millions of potential drug-disease combinations to be considered with only a small fraction being viable. In silico predictions of drug-disease associations can be invaluable for reducing the size of the search space. In this work we present a novel network of drugs and the diseases they treat, compiled using a combination of existing textual and machine-readable databases, natural-language processing tools, and hand curation, and analyze it using network-based link prediction methods to identify potential drug-disease combinations. We measure the efficacy of these methods using cross-validation tests and find that several methods, particularly those based on graph embedding and network model fitting, achieve impressive prediction performance, significantly better than previous approaches, with area under the ROC curve above 0.95 and average precision almost a thousand times better than chance.

Repurposing of existing drugs to treat new diseases is an important avenue for drug development, but there are millions of potential drug-disease combinations to be considered with only a small fraction being viable. In this work we show how network-based link prediction methods can be used to identify promising candidates for repurposing. We assemble a novel network of drugs and the diseases they treat using a combination of existing textual and machine-readable databases, natural-language processing tools, and hand curation, then test a range of link prediction methods on it, finding that the best such methods achieve impressive performance, correctly identifying more than 90% of repurposing candidates in cross-validation tests.